Trial site
Luxderm Specjalistyczny Gabinet Dermatologiczny Prof. Dr. Hab. N. Med. Dorota Krasowska
- 18running trials
- 6closed trials
The trials here
What the 24 trials at this site are about, from their registry records.
- Conditions
- Psoriasis8 trials
- Atopic dermatitis (eczema)6 trials
- Chronic spontaneous urticaria5 trials
- Hidradenitis suppurativa4 trials
- Vitiligo1 trial
- Phase
- Phase 318 trials
- Phase 25 trials
- Phase 2/31 trial
- Status
- Active, not recruiting8 trials
- Recruiting8 trials
- Completed5 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Pfizer3 trials
- Takeda3 trials
- Alumis Inc2 trials
- Bristol-Myers Squibb2 trials
- Celldex Therapeutics2 trials
- and 10 more
Running trials
Recruiting
Recruiting
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Recruiting
Recruiting
Enrolling by invitation
Active, not recruiting
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Active, not recruiting
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
Active, not recruiting
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atopic dermatitis (eczema)3 recruiting
- Chronic spontaneous urticaria3 recruiting
- Psoriasis3 recruiting
- Hidradenitis suppurativa1 recruiting
- Vitiligo1 recruiting
Closed trials
Recruiting
Completed
A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis
Completed
Completed
Completed
BP11 Versus EU-Approved Xolair® in Patients With Chronic Spontaneous Urticaria
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026